M. Miksits

Expression of sulfotransferases and sulfatases in human breast cancer: impact on resveratrol metabolism.

M. Miksits, Katrin Wlcek, M. Svoboda, 2010, Cancer letters.

Uptake of diet resveratrol into the human low-density lipoprotein. Identification and quantification of resveratrol metabolites by liquid chromatography coupled with tandem mass spectrometry.

R. Lamuela-Raventós, M. Miksits, W. Jaeger, 2005, Analytical chemistry.

Glucuronidation of piceatannol by human liver microsomes: major role of UGT1A1, UGT1A8 and UGT1A10

M. Miksits, T. Szekeres, W. Jäger, 2010, The Journal of pharmacy and pharmacology.

Pharmacokinetics of voriconazole during continuous venovenous haemodiafiltration.

M. Miksits, W. Jaeger, F. Thalhammer, 2007, The Journal of antimicrobial chemotherapy.

Sulfation of resveratrol in human liver: Evidence of a major role for the sulfotransferases SULT1A1 and SULT1E1

M. Miksits, T. Thalhammer, T. Szekeres, 2005, Xenobiotica; the fate of foreign compounds in biological systems.

In‐vitro sulfation of piceatannol by human liver cytosol and recombinant sulfotransferases

M. Miksits, T. Szekeres, W. Jäger, 2009 .

Antitumor activity of resveratrol and its sulfated metabolites against human breast cancer cells.

M. Miksits, Katrin Wlcek, M. Svoboda, 2009, Planta medica.

In-vitro sulfation of piceatannol by human liver cytosol and recombinant sulfotransferases.

M. Miksits, T. Szekeres, W. Jäger, 2009, The Journal of pharmacy and pharmacology.

Metabolism of resveratrol in breast cancer cell lines: impact of sulfotransferase 1A1 expression on cell growth inhibition.

M. Miksits, T. Thalhammer, T. Szekeres, 2008, Cancer letters.